Aim:This executive summary of the clinical practice guideline for the evaluation and diagnosis of chest pain provides recommendations and algorithms for clinicians to assess and diagnose chest pain in adult patients.Methods:A comprehensive literature search was conducted from November 11, 2017, to May 1, 2020, encompassing studies, reviews, and other evidence conducted on human subjects that were published in English from PubMed, EMBASE, the Cochrane Collaboration, Agency for Healthcare Research and Quality reports, and other relevant databases. Additional relevant studies, published through April 2021, were also considered.Structure:Chest pain is a frequent cause for emergency department visits in the United States. The “2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR Guideline for the Evaluation and Diagnosis of Chest Pain” provides recommendations based on contemporary evidence on the assessment and evaluation of chest pain. These guidelines present an evidence-based approach to risk stratification and the diagnostic workup for the evaluation of chest pain. Cost-value considerations in diagnostic testing have been incorporated and shared decision-making with patients is recommended.

中文翻译：

---

2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR 胸痛评估和诊断指南：执行摘要：美国心脏病学会/美国心脏协会临床实践指南联合委员会报告

目的：这份胸痛评估和诊断临床实践指南的执行摘要为临床医生评估和诊断成人胸痛提供了建议和算法。方法：从 2017 年 11 月 11 日到 5 月进行了全面的文献检索2020 年 1 月，包括 PubMed、EMBASE、Cochrane 协作组织、医疗保健研究和质量报告机构以及其他相关数据库以英文发表的对人类受试者进行的研究、评论和其他证据。还考虑了截至 2021 年 4 月发表的其他相关研究。结构：在美国，胸痛是急诊就诊的常见原因。“2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR 胸痛评估和诊断指南”提供了基于当代胸痛评估和评估证据的建议。这些指南提出了一种基于证据的风险分层方法和评估胸痛的诊断检查。已纳入诊断测试中的成本价值考虑，并建议与患者共同决策。